1,3,4,5-四氢-2H-1-苯并氮杂卓-2-酮 | 4424-80-0

• 物质功能分类: 有机原料 - 酮类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯氮卓类
• 中文名称: 1,3,4,5-四氢-2H-1-苯并氮杂卓-2-酮
• 中文别名: 1,3,4,5-四氢-1-苯并杂卓-2-酮；4,5-二氢-1H-苯并[b]吖庚因-2(3H)-酮
• 英文名称: 2,3,4,5-tetrahydro-1H-1-benzo[b]azepin-2-one
• 英文别名: 1,3,4,5-tetrahydro-2H-benzo[b]azepin-2-one；1,3,4,5-tetrahydro-2H-1-benzazepin-2-one；4,5-dihydro-1H-benzo[b]azepin-2(3H)-one；1,3,4,5-tetrahydrobenzo[b]azepin-2-one；2,3,4,5-tetrahydro-1H-1-benzazepin-2-one；1,3,4,5-tetrahydro-1-benzazepin-2-one
• CAS: 4424-80-0
• 化学式: C₁₀H₁₁NO
• mdl: MFCD00024149
• 分子量: 161.203
• InChiKey: HRVRAYIYXRVAPR-UHFFFAOYSA-N

物化性质

• 熔点：
  143-144 °C
• 沸点：
  339.0±21.0 °C(Predicted)
• 密度：
  1.100±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于DMSO（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2933990090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  存放于惰性气体中，避免与空气接触。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1,3,4,5-Tetrahydro-2H-1-benzazepin-2-one
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1,3,4,5-Tetrahydro-2H-1-benzazepin-2-one
CAS number: 4424-80-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H11NO
Molecular weight: 161.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1,3,4,5-四氢-2H-1-苯并氮杂卓-2-酮 在 palladium on activated charcoal 氢氧化钾 、 sodium hydroxide 、 sodium azide 、 五氯化磷 、 四丁基溴化铵 、 氢气 、 sodium acetate 、 sodium cyanoborohydride 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 溶剂黄146 、 二甲基亚砜 、 xylene 为溶剂， 25.0~90.0 ℃ 、303.98 kPa 条件下， 反应 9.0h， 生成 盐酸贝那普利
  参考文献：
  名称：

  血管紧张素转化酶的（羧基烷基）氨基取代的双环内酰胺抑制剂的合成及其生物学性质。

  摘要：

  有效的血管紧张素转化酶抑制剂（3S）-1-（羧甲基）-3-[[（1S）-1-羧-3-苯基丙基]氨基]-2,3,4,5-四氢-1H- [的合成1]苯并ze庚因-2-酮（4b； CGS 14831）和相关的单酯前药（17a； CGS 14824A）与六元和八元环类似物的制备细节一起进行了描述。讨论了化合物的抑制能力和体内生物学活性。数据表明17a具有与依那普利相当的生物学特性。

  DOI：

  10.1021/jm00148a023
• 作为产物：
  描述：

  3,4-二氢-1(2H)-萘酮 在 cesiumhydroxide monohydrate 、 copper(II) bis(trifluoromethanesulfonate) 、 hydroxylamine-O-sulfonic acid 作用下， 以 二氯甲烷 、 2,2,2-三氟乙醇 为溶剂， 反应 32.0h， 以75%的产率得到1,3,4,5-四氢-2H-1-苯并氮杂卓-2-酮
  参考文献：
  名称：

  使用羟胺-O-磺酸 (HOSA) 进行 Cu(OTf)2 催化的酮贝克曼重排。

  摘要：

  摘要 酮到仲酰胺的贝克曼重排（BKR）通常需要苛刻的反应条件，限制了其实用性和范围。在此，描述了使用羟胺-O-磺酸(HOSA)（一种商业水溶性胺化剂）在温和反应条件下Cu(OTf) 2催化的酮的BKR。该方法与大多数官能团相容，并以良好至优异的产率直接提供所需的酰胺。 酮到仲酰胺的贝克曼重排（BKR）通常需要苛刻的反应条件，限制了其实用性和范围。在此，描述了使用羟胺-O-磺酸(HOSA)（一种商业水溶性胺化剂）在温和反应条件下Cu(OTf) 2催化的酮的BKR。该方法与大多数官能团相容，并以良好至优异的产率直接提供所需的酰胺。

  DOI：

  10.1055/s-0039-1690005

文献信息

• [EN] PYRROLOTRIAZINES AS ALK AND JAK2 INHIBITORS<br/>[FR] PYRROLOTRIAZINES EN TANT QU'INHIBITEURS D'ALK ET DE JAK2
  申请人：CEPHALON INC

  公开号：WO2010071885A1

  公开（公告）日：2010-06-24

  The present invention provides a compound of formula (I) or a salt form thereof, wherein Q1, Q2, Q3, and Q4 are as defined herein. The compound of formula (I) has ALK and/or JAK2 inhibitory activity, and may be used to treat proliferative disorders.

  本发明提供了一种式（I）的化合物或其盐形式，其中Q1、Q2、Q3和Q4如本文所定义。式（I）的化合物具有ALK和/或JAK2抑制活性，并可用于治疗增殖性疾病。
• SO₂ F₂ -Activated Efficient Beckmann Rearrangement of Ketoximes for Accessing Amides and Lactams
  作者：Guofu Zhang、Yiyong Zhao、Lidi Xuan、Chengrong Ding

  DOI：10.1002/ejoc.201900844

  日期：2019.8.15

  A novel protocol for the efficient activation of the Beckmann rearrangement utilizing the readily available sulfuryl fluoride (SO2F2 gas) is reported. The substrate scope of this methodology has been demonstrated by 37 examples with good to nearly quantitative isolated yields in a short time. A tentative mechanism was proposed involving formation and elimination of sulfonyl ester.

  报道了一种利用容易获得的硫酰氟（SO 2 F 2气体）有效激活贝克曼重排的新方案。该方法的底物范围已通过37个实例证明，并在短时间内获得了良好至近乎定量的分离产率。提出了一种尝试性的机制，涉及形成和消除磺酰基酯。
• [EN] OXAZOLIDINONE DERIVATES N-SUBSTITUTED BY A TRICYCLIC RING, FOR USE AS ANTIBACTERIAL AGENTS<br/>[FR] DERIVES D'OXAZOLIDINONES N-SUBSTITUES PAR UN NOYAU TRICYCLIQUE, DESTINES A ETRE UTILISES EN TANT QU'AGENTS ANTIBACTERIENS
  申请人：WARNER LAMBERT CO

  公开号：WO2004069245A1

  公开（公告）日：2004-08-19

  Compounds of formula (I) and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula (I) as well as pharmaceutically acceptable compositions comprising compounds of formula (I). Compounds of formula (I) as disclosed herein can be used in a variety of applications including use as antibacterial P is a tricyclic ring system as defined in claiml.

  公式（I）的化合物及其制备方法已被披露。进一步披露了制备公式（I）生物活性化合物的方法，以及包含公式（I）化合物的药用可接受组合物的方法。本文披露的公式（I）化合物可用于各种应用，包括用作抗菌剂P是在权利要求1中定义的三环环系统。
• [EN] TRICYCLIC MODULATORS OF TNF SIGNALING<br/>[FR] MODULATEURS TRICYCLIQUES DE LA SIGNALISATION DU TNF
  申请人：ABBVIE INC

  公开号：WO2016168641A1

  公开（公告）日：2016-10-20

  The invention provides tricyclic heterocyclic compounds, pharmaceutically acceptable salts, prodrugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the invention may be useful for treating immunological and oncological conditions.

  这项发明提供了三环杂环化合物，其药用盐、前药、生物活性代谢物、立体异构体和同分异构体，其中变量在此处定义。该发明的化合物可能对治疗免疫和肿瘤疾病有用。
• Vinylogous carbinolamine tumor inhibitors. 23. Synthesis and antileukemic activity of bis[[(carbamoyl)oxy]methyl]-substituted pyrrolo[2,1-a]isoquinolines, pyrrolo[1,2-a]quinolines, pyrrolo[2,1-a]isobenzazepines, and pyrrolo[1,2-a]benzazepines
  作者：Wayne K. Anderson、Arvela R. Heider、Natarajan Raju、Jeffery A. Yucht

  DOI：10.1021/jm00119a008

  日期：1988.11

  compound or with a mesoionic oxazolone intermediate. All of the bis(carbamates) were active in vivo against P388 lymphocytic leukemia with 5,6-dihydro-8-methoxy-1,2- bis(hydroxymethyl)pyrrolo[2,1-a]isoquinoline bis[N-(2-propyl)carbamate] (3c) showing the highest level of activity.

  通过与合适的Resissert化合物的三氟甲磺酸盐或与中离子的恶唑酮中间体进行1,3-偶极环加成反应，合成了一系列双[[（氨基甲酰基）氧基]甲基]-取代的吡咯稠合的三环杂环。所有的双（氨基甲酸酯）在体内均具有5,6-二氢-8-甲氧基-1,2-双（羟甲基）吡咯并[2,1-a]异喹啉双[N-（2-）对P388淋巴细胞性白血病的活性。丙基]氨基甲酸酯]（3c）表现出最高的活性水平。

表征谱图